CMS has issued its latest proposal rule on Medicaid drug pricing and rebates. The proposal doesn't clear up all areas of uncertainty and will add administrative costs for manufacturers. It…
Read More
The Massachusetts reform rolls on, with the state's residents generally still okay with the changes, although cost continues to be a problem. An article in Health Affairs sums up the…
Read More
The Government Accountability Office issues a report on use of implantable medical devices in hospitals, finding that they pay widely varying prices, suggesting that it is often too much, some…
Read More